Monte Rosa Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Form of Pre-Funded Warrant (Filed With SEC on May 16, 2024)
- Underwriting Agreement, dated May 15, 2024, by and between Monte Rosa Therapeutics, Inc. and TD Securities (USA) LLC, as representative of the several underwriters listed on... (Filed With SEC on May 16, 2024)
- Securities Purchase Agreement, dated October 26, 2023 (Filed With SEC on October 26, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 26, 2023)
- 2021 Employee Stock Purchase Plan (Filed With SEC on June 21, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 21, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 21, 2021)
- Contribution and Exchange Agreement, dated September 1, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
- Contribution and Exchange Agreement, dated April 14, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
- 2020 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on June 4, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 4, 2021)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated March 11, 2021 (Filed With SEC on June 4, 2021)
